Superpower peptides available for pre-order. Get first access.

Not FDA-approved

Bones & muscles

GHRP-6

EvidenceLow research
ClassGHRP / ghrelin agonist

GHRP-6 is a synthetic ghrelin-mimic peptide that raises growth hormone and appetite. Learn how it works, what human data exist, and why it is not FDA-approved.

Reviewed by
William Maish, MD MBA MPH, Clinical Product Lead
Published
October 5, 2026
Last updated
October 5, 2026

Key takeaway

GHRP-6 is one of the original synthetic ghrelin-mimic peptides, sold in the wellness market to raise the body's own growth hormone and stimulate appetite. Human data are limited to short studies of growth hormone release, with no controlled trials proving the marketed muscle, recovery, or anti-aging benefits. As of 2026 it is not FDA-approved and is banned in sport.

At a glance

FDA statusNon-FDA-approved peptide sold in the wellness/gray market
What it isGhrelin-receptor agonist / growth hormone-releasing peptide that markedly increases appetite
ResearchHuman data are limited to short pharmacology studies; the marketed benefits are unproven
SportProhibited by WADA at all times
Evidence strengthLow research

What is GHRP-6?

GHRP-6 is a synthetic six-amino acid peptide and one of the first growth hormone-releasing peptides developed. It is sold through wellness and "research peptide" channels and promoted for muscle gain, recovery, and appetite stimulation. It was never marketed as an approved drug.

How does it work?

GHRP-6 activates the growth hormone secretagogue receptor (the ghrelin receptor), prompting the pituitary to release growth hormone, and it is proposed to act partly by blunting the body's growth-hormone "brake," somatostatin.

Compared with newer peptides it is less selective, notably:

Laboratory work also describes growth hormone secretagogue receptors in heart1 and blood-vessel tissue, which is the basis for preclinical interest in other effects. The marketed benefits are extrapolated from the growth hormone rise. This describes the proposed mechanism, separate from proven outcomes.

Is it FDA-approved?

No. GHRP-6 is not approved by the FDA and has no approved product. It has been treated as not eligible for routine 503A compounding in the U.S. and is not approved for performance or anti-aging. In sport, growth hormone-releasing peptides including GHRP-6 are prohibited at all times under the WADA list.

What does the research show?

The human evidence is short pharmacology. According to PubMed, an infusion study2 in healthy men found GHRP-6 raised growth hormone and IGF-1 while the pituitary remained responsive, a hormone-level result rather than a clinical outcome. Cardiovascular and cell-protective effects are described mainly in preclinical work and reviews3. No controlled human trials support the marketed muscle, fat, recovery, or anti-aging uses.

More for bones & muscles

Sources: a growth hormone pharmacology study (Jaffe et al., Journal of Clinical Endocrinology & Metabolism, 1993, DOI: 10.1210/jcem.77.6.79033132) and a review of growth hormone secretagogues (Cao et al., Trends in Endocrinology & Metabolism, 2005, DOI: 10.1016/j.tem.2005.11.0043), both indexed on PubMed; and the WADA Prohibited List. This document is educational, is not medical advice or a health claim, and is not an offer to sell any product.